Reneo Pharmaceuticals Ownership | Who Owns Reneo Pharmaceuticals?
Reneo Pharmaceuticals Ownership Summary
Reneo Pharmaceuticals is owned by 86.29% institutional investors, 5.19% insiders, and 8.52% retail investors. Nea management company is the largest institutional shareholder, holding 14.32% of RPHM shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 17.83% of its assets in Reneo Pharmaceuticals shares.
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Nea management company | 4.79M | 14.32% | $7.23M |
| Tang capital management | 3.00M | 8.97% | $4.52M |
| Highbridge capital management | 2.92M | 8.72% | $4.40M |
| Carlyle group | 2.70M | 8.08% | $4.16M |
| Bml capital management | 2.67M | 8.00% | $4.04M |
| Rivervest venture management | 2.53M | 7.58% | $3.83M |
| Octagon capital advisors lp | 2.25M | 6.73% | $3.40M |
| Aisling capital management lp | 886.08K | 2.65% | $1.34M |
| Vanguard group | 882.10K | 2.64% | $1.33M |
| Nantahala capital management | 547.80K | 1.64% | $846.36K |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Rivervest venture management | 2.53M | 56.07% | $3.83M |
| Bml capital management | 2.67M | 2.88% | $4.04M |
| Aldebaran capital | 447.62K | 0.63% | $675.90K |
| Aisling capital management lp | 886.08K | 0.58% | $1.34M |
| Nea management company | 4.79M | 0.54% | $7.23M |
| Octagon capital advisors lp | 2.25M | 0.53% | $3.40M |
| Tang capital management | 3.00M | 0.46% | $4.52M |
| Carlyle group | 2.70M | 0.39% | $4.16M |
| Acuitas investments | 406.21K | 0.33% | $613.38K |
| Highbridge capital management | 2.92M | 0.14% | $4.40M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Nantahala capital management | 547.80K | 0.05% | 547.80K |
| Bml capital management | 2.67M | 2.88% | 494.28K |
| Vestal point capital, lp | 545.00K | 0.06% | 249.63K |
| Highbridge capital management | 2.92M | 0.14% | 178.81K |
| Millennium management | 109.99K | 0.00% | 109.99K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Rock springs capital management lp | - | - | -751.73K |
| Blackrock | 293.65K | - | -700.01K |
| State street | 71.64K | - | -175.79K |
| Opaleye management | - | - | -165.00K |
| Renaissance | 442.20K | 0.00% | -151.09K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Nantahala capital management | 547.80K | 0.05% | 547.80K | $846.36K |
| Squarepoint ops | 19.49K | - | 19.49K | $29.43K |
| Point72 asia (singapore) pte. | 18.03K | 0.01% | 18.03K | $27.22K |
| Aqr capital management | 10.40K | - | 10.40K | $15.71K |
| Mirae asset global investments | 998.00 | - | 998.00 | $1.61K |
Sold Out
| Holder | Change |
|---|---|
| Nelson, van denburg & campbell wealth management group | -2.00 |
| Nisa investment advisors | -40.00 |
| Advisor group | -41.00 |
| Farther finance advisors | -117.00 |
| Amalgamated bank | -327.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2024 | 49 | -20.97% | 28,839,381 | 5.73% | 86 | 1.30% | 21 | -34.38% | 14 | -26.32% |
| Jun 30, 2024 | 62 | -6.06% | 27,277,054 | -0.32% | 81 | 1.25% | 32 | 14.29% | 19 | - |
| Mar 31, 2024 | 66 | -15.38% | 27,363,476 | 8.32% | 80 | 1.45% | 28 | -40.43% | 19 | 18.75% |
| Dec 31, 2023 | 78 | 32.20% | 25,262,300 | -7.60% | 74 | 0.91% | 47 | 46.88% | 16 | 23.08% |
| Sep 30, 2023 | 59 | 15.69% | 27,339,727 | 4.28% | 90 | 0.83% | 32 | -17.95% | 13 | 160.00% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 596.11K | 17.83% | - |
| Vanguard Institutional Extnd Mkt Idx Tr | 278.54K | 8.33% | - |
| iShares Biotechnology ETF | 145.72K | 4.36% | 280.00 |
| iShares Micro-Cap ETF | 46.47K | 1.39% | - |
| NT R2000 Index Fund - NL | 35.07K | 1.05% | -138.00 |
| NT R2000 Index Fund - DC - NL - 2 | 27.75K | 0.83% | -208.00 |
| NT R2000 Growth Index Fund - NL | 26.00K | 0.78% | - |
| iShares Nasdaq US Biotech ETF USD Acc | 23.21K | 0.69% | - |
| The Vanguard Russell 2000 Growth Index | 13.69K | 0.41% | - |
| Northern Trust Russell 2000 Growth Index | 13.35K | 0.40% | -5.92K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Sep 24, 2024 | Leonard Braden Michael | - | Buy | $41.87K |
| Sep 25, 2024 | Leonard Braden Michael | - | Buy | $102.87K |
| Sep 18, 2024 | Leonard Braden Michael | - | Buy | $1.13K |
| Sep 17, 2024 | Leonard Braden Michael | - | Buy | $75.11K |
| Sep 16, 2024 | Leonard Braden Michael | - | Buy | $236.87K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2024 Q3 | 9 | - |
| 2024 Q2 | 2 | - |
| 2023 Q3 | - | 1 |
| 2023 Q2 | 1 | 1 |
| 2022 Q4 | - | - |
RPHM Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools